Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BX-U007
- Development stage
- Preclinical
- Lead developer
- Baylx
- Modality
- Small Molecules
01
Overview
BX-U007 is a preclinical-stage small molecule drug candidate developed by Bionure (now Accure Therapeutics) for the treatment of neurodegenerative diseases, specifically Multiple Sclerosis (MS). It belongs to a series of neurotrophin mimetics designed to provide neuroprotection and promote remyelination. BX-U007 acts as a modulator of the p75 neurotrophin receptor (p75NTR), a target involved in neuronal survival and myelin repair. By mimicking the activity of endogenous neurotrophins, the compound aims to prevent axonal loss and stimulate the differentiation of oligodendrocyte precursor cells into mature, myelin-producing cells. While its sibling compound BX-U001 (ACT-01) has advanced into clinical trials for optic neuritis and MS, BX-U007 remains in the preclinical phase as part of Accure's broader portfolio of neuroprotective assets.
- Other names
- BX-U007BX-U-007BX-U 007
02
Targets
NGFR (p75NTR)
Beyond the preview
Go deeper on BX-U007.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BX-U007.